This study showed a trend for a decrease in 66.7% of subjects when they took L. reuteri DSM17648, with the biggest decrease occurring in the abdominal symptoms subgroup where GSRS scores decreased by 16.7%.
← all excerpts
The effect of <i>Lactobacillus reuteri</i> supplementation in <i>Helicobacter pylori</i> infection: a placebo-controlled, single-blind study.
1
—
—